ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,364.42
0.38%
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs Yen
156.637
-0.05%
Brent Oil
81.47
-0.07%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. C4 Therapeutics Inc (CCCC)

  7. C4 Therapeutics Inc (CCCC) ニュース

CCCC

C4 Therapeutics (CCCC)

C4 Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CCCC
日付受信時刻ニュースソース見出しコード企業名
2024/05/0820 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CCCCC4 Therapeutics Inc
2024/05/0820 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/05/0820 : 00GlobeNewswire Inc.C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CCCCC4 Therapeutics Inc
2024/04/3005 : 01GlobeNewswire Inc.C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CCCCC4 Therapeutics Inc
2024/04/0920 : 00GlobeNewswire Inc.C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology ForumNASDAQ:CCCCC4 Therapeutics Inc
2024/04/0821 : 00GlobeNewswire Inc.C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024NASDAQ:CCCCC4 Therapeutics Inc
2024/03/0909 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0909 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0909 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0909 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0909 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0906 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0606 : 30GlobeNewswire Inc.C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024NASDAQ:CCCCC4 Therapeutics Inc
2024/03/0421 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/03/0421 : 00GlobeNewswire Inc.C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic ProteinsNASDAQ:CCCCC4 Therapeutics Inc
2024/02/2223 : 01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CCCCC4 Therapeutics Inc
2024/02/2221 : 20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CCCCC4 Therapeutics Inc
2024/02/2221 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/02/2221 : 00GlobeNewswire Inc.C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1607 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1607 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1607 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1607 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1607 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/02/1423 : 21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/02/0600 : 24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CCCCC4 Therapeutics Inc
2024/02/0223 : 34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/01/1306 : 01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CCCCC4 Therapeutics Inc
2024/01/1121 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/01/1006 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CCCC

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
FX
USDGBP
US Dollar vs Sterling
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
FX
USDJPY
US Dollar vs Yen
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有